Literature DB >> 33099279

Cell therapy for acute myocardial infarction: Requiescat in Pace.

Roberto Bolli1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33099279     DOI： 10.1093/eurheartj/ehaa802

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

1.  Recommendations for nomenclature and definition of cell products intended for human cardiovascular use.

Authors:  Doris A Taylor; Lourdes Chacon-Alberty; Luiz C Sampaio; Mariana Gonzalez Del Hierro; Emerson C Perin; Fernanda C P Mesquita; Timothy D Henry; Jay H Traverse; Carl J Pepine; Joshua M Hare; Michael P Murphy; Phillip C Yang; Keith L March; Rachel W Vojvodic; Ray F Ebert; Roberto Bolli
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

2.  CAESAR's legacy: a new era of rigor in preclinical studies of cardioprotection.

Authors:  Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2021-05-20       Impact factor: 17.165

3.  Cardiac Cell Therapy Fails to Rejuvenate the Chronically Scarred Rodent Heart.

Authors:  Ronald J Vagnozzi; Rajesh K Kasam; Michelle A Sargent; Jeffery D Molkentin
Journal:  Circulation       Date:  2021-07-26       Impact factor: 39.918

Review 4.  Stem cells therapy in acute myocardial infarction: a new era?

Authors:  R G Carbone; A Monselise; G Bottino; S Negrini; F Puppo
Journal:  Clin Exp Med       Date:  2021-01-23       Impact factor: 3.984

5.  Cell-Based Therapies for Heart Failure.

Authors:  Antonio Carlos Campos de Carvalho; Tais H Kasai-Brunswick; Adriana Bastos Carvalho
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

6.  Rejuvenating the Aging Heart by Enhancing the Expression of the Cisd2 Prolongevity Gene.

Authors:  Chi-Hsiao Yeh; Yi-Ju Chou; Ting-Kuan Chu; Ting-Fen Tsai
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

7.  The sad plight of cell therapy for heart failure: causes and consequences.

Authors:  Roberto Bolli; Xian-Liang Tang
Journal:  J Cardiovasc Aging       Date:  2022-03-02

8.  First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction.

Authors:  Lien-Cheng Hsiao; Yen-Nien Lin; Woei-Cherng Shyu; Ming Ho; Chiung-Ray Lu; Shih-Sheng Chang; Yu-Chen Wang; Jan-Yow Chen; Shang-Yeh Lu; Mei-Yao Wu; Keng-Yuan Li; Yu-Kai Lin; Wen-Yih I Tseng; Mao-Yuan Su; Chin-Ting Hsu; Cheng-Kang Tsai; Lu-Ting Chiu; Chien-Lin Chen; Cheng-Li Lin; Kai-Chieh Hu; Der-Yang Cho; Chang-Hai Tsai; Kuan-Cheng Chang; Long-Bin Jeng
Journal:  Front Cardiovasc Med       Date:  2022-08-09

Review 9.  Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.

Authors:  Stefan Frantz; Moritz Jens Hundertmark; Jeanette Schulz-Menger; Frank Michael Bengel; Johann Bauersachs
Journal:  Eur Heart J       Date:  2022-07-14       Impact factor: 35.855

Review 10.  Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.

Authors:  Roberto Bolli; Mitesh Solankhi; Xiang-Liang Tang; Arunpreet Kahlon
Journal:  Cardiovasc Res       Date:  2022-03-16       Impact factor: 10.787
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.